Fulgent Genetics, Inc.
Fulgent Genetics, Inc. (NASDAQ: FLGT) is trading at $22.08, about ₹2,121 at today's USD/INR rate, as of 29 Sep 2026, 4:00 PM ET, down 1.25% today. Indian residents can buy Fulgent Genetics from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
$21.88
Today's high
$22.59
52 week low
$13.46
52 week high
$31.04
FLGT opened at $22.28, closed previously at $22.36, and has traded between $13.46 and $31.04 over the past 52 weeks.
About
Fulgent Genetics, Inc., together with its affiliated companies, offers a comprehensive suite of COVID-19, molecular diagnostic, and genetic testing services to healthcare providers and individuals globally. Their diverse array of genetic tests covers a wide range of applications, including extensive oncology panels and solid tumor molecular profiling for cancer identification, Beacon carrier screening for inherited conditions, and specialized rapid whole genome testing for critically ill infants in NICU and PICU units. Other offerings include a newborn genetic analysis panel, a front-line test to sequence ataxia-related variants, and patient-initiated genetic testing via Picture Genetics. They also provide comprehensive whole exome, clinical exome, whole genome, mutation, and repeat expansion testing, alongside research service tests. For COVID-19, the company delivers next-generation sequencing, reverse transcription polymerase chain reaction (RT-PCR), and antigen-based diagnostic solutions for SARS-CoV-2. Beyond genetic and COVID-19 diagnostics, Fulgent Genetics performs advanced laboratory analyses such as flow cytometry for cell analysis and malignancy monitoring, fluorescence in-situ hybridization (FISH) for specific DNA sequence detection, immunohistochemistry (IHC) to visualize cellular antigens, and cytogenetics for assessing chromosomal anomalies, in addition to molecular testing for both hematopoietic and solid tumors. Their clientele is broad, including insurance companies, hospitals, medical institutions, fellow laboratories, government agencies, payors, municipal bodies, major corporations, and direct patients. The company has formed a strategic partnership with Helio Health, Inc. to commercialize blood-based early cancer detection tests. Founded in 2011 and headquartered in Temple City, California, the company was previously known as Fulgent Diagnostics, Inc. before adopting its current name in August 2016.
Key statistics
Avg. volume
336.57K
Market cap
$627.09M
P/E Ratio
-7.83
Price-to-sales ratio
1.94
Enterprise value
$766.00M
Free cash flow yield
-15.36%
Debt-to-equity ratio
0.01
Return on equity
-5.44%
ROIC
-7.09%
Beta
0.93
Dividend yield
0.00%
Last dividend
$0.00
Financial overview
Revenue
$322.67M
Earnings per share
-$1.97
Free cash flow
-$124.21M
Net profit margin
-26.05%
Gross margin
35.58%
EBITDA
-$45.83M
Revenue growth
13.83%
Similar securities
This is not an investment recommendation
How to buy Fulgent Genetics from India
Indian residents can buy Fulgent Genetics shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.
Search for Fulgent Genetics and place an order
Find Fulgent Genetics by name or by its ticker, FLGT, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Fulgent Genetics trades 7:00 pm – 1:30 am IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Fulgent Genetics position in USD and INR. Fulgent Genetics pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Fulgent Genetics from India
Trading and taxes when buying Fulgent Genetics from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm ET
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneFulgent Genetics does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
- US estate tax
- May applyUS-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons.US estate tax calculator
Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
FAQs
Can Indian residents buy Fulgent Genetics stock?
Yes. Fulgent Genetics (FLGT) has been listed on NASDAQ since 2016, in the Medical - Diagnostics & Research industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.
How much does one Fulgent Genetics share cost in rupees?
One Fulgent Genetics share is $22.08 — about ₹2,121 at a USD/INR rate of 96.06 on 29 Sep 2026. Both the Fulgent Genetics price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Fulgent Genetics from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
Can I buy whole shares of Fulgent Genetics?
Yes. One Fulgent Genetics share is $22.08, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Fulgent Genetics.
How are gains on Fulgent Genetics shares taxed in India?
The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Fulgent Genetics price. Paasa issues a capital-gains statement for your return.
Does Fulgent Genetics pay a dividend?
No. Fulgent Genetics does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Fulgent Genetics from India?
NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.
Is there estate or inheritance tax on Fulgent Genetics shares held from India?
US-situs assets such as US-listed shares can be exposed to US estate tax for non-US persons. It applies to your overall holdings in that jurisdiction rather than to any one position. Paasa's US estate tax calculator shows the exposure for a given portfolio value.
Do I have to declare Fulgent Genetics shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Fulgent Genetics holding, its cost and its closing value.
How do I sell Fulgent Genetics and bring the money back to India?
You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.